Sodium in PDB 7nfb: Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide
Protein crystallography data
The structure of Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide, PDB code: 7nfb
was solved by
M.Kriegel,
Y.A.Muller,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
27.73 /
1.33
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.854,
81.526,
58.464,
90,
108.46,
90
|
R / Rfree (%)
|
14.2 /
17.8
|
Other elements in 7nfb:
The structure of Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide
(pdb code 7nfb). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 3 binding sites of Sodium where determined in the
Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide, PDB code: 7nfb:
Jump to Sodium binding site number:
1;
2;
3;
Sodium binding site 1 out
of 3 in 7nfb
Go back to
Sodium Binding Sites List in 7nfb
Sodium binding site 1 out
of 3 in the Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na602
b:25.7
occ:1.00
|
HE2
|
B:HIS501
|
2.0
|
22.8
|
1.0
|
HG
|
A:LEU497
|
2.7
|
24.5
|
1.0
|
ND1
|
A:HIS501
|
2.7
|
18.7
|
1.0
|
HB3
|
A:HIS501
|
2.8
|
20.1
|
1.0
|
NE2
|
B:HIS501
|
2.9
|
19.0
|
1.0
|
O
|
A:LEU497
|
2.9
|
19.0
|
1.0
|
HD12
|
A:LEU497
|
3.0
|
25.5
|
1.0
|
HD13
|
A:LEU497
|
3.0
|
25.5
|
1.0
|
CD1
|
A:LEU497
|
3.3
|
21.2
|
1.0
|
CG
|
A:LEU497
|
3.4
|
20.4
|
1.0
|
CG
|
A:HIS501
|
3.5
|
17.1
|
1.0
|
CB
|
A:HIS501
|
3.5
|
16.8
|
1.0
|
H
|
A:HIS501
|
3.5
|
19.6
|
1.0
|
C
|
A:LEU497
|
3.7
|
18.3
|
1.0
|
CE1
|
A:HIS501
|
3.7
|
18.3
|
1.0
|
HG21
|
B:ILE487
|
3.7
|
23.2
|
1.0
|
HD11
|
B:LEU497
|
3.7
|
36.2
|
0.6
|
CE1
|
B:HIS501
|
3.8
|
18.9
|
1.0
|
HE1
|
B:HIS501
|
3.8
|
22.6
|
1.0
|
CD2
|
B:HIS501
|
3.9
|
18.9
|
1.0
|
HA
|
A:GLN498
|
3.9
|
21.8
|
1.0
|
HE1
|
A:HIS501
|
3.9
|
22.0
|
1.0
|
HD2
|
B:HIS501
|
4.0
|
22.6
|
1.0
|
HD12
|
B:LEU497
|
4.1
|
36.2
|
0.6
|
HD22
|
B:LEU497
|
4.2
|
23.7
|
0.4
|
N
|
A:HIS501
|
4.2
|
16.3
|
1.0
|
HD21
|
A:LEU497
|
4.2
|
25.6
|
1.0
|
HB2
|
A:GLN500
|
4.2
|
20.5
|
1.0
|
HB2
|
A:HIS501
|
4.2
|
20.1
|
1.0
|
HD12
|
B:ILE487
|
4.2
|
25.2
|
1.0
|
HD11
|
A:LEU497
|
4.3
|
25.5
|
1.0
|
CD1
|
B:LEU497
|
4.4
|
30.2
|
0.6
|
HA
|
A:LEU497
|
4.4
|
22.4
|
1.0
|
CD2
|
A:LEU497
|
4.4
|
21.3
|
1.0
|
CA
|
A:HIS501
|
4.4
|
16.7
|
1.0
|
CB
|
A:LEU497
|
4.5
|
19.3
|
1.0
|
CA
|
A:LEU497
|
4.5
|
18.7
|
1.0
|
N
|
A:GLN498
|
4.5
|
17.9
|
1.0
|
HG13
|
B:ILE487
|
4.6
|
22.3
|
1.0
|
CA
|
A:GLN498
|
4.6
|
18.2
|
1.0
|
CG2
|
B:ILE487
|
4.7
|
19.3
|
1.0
|
CD2
|
A:HIS501
|
4.7
|
16.9
|
1.0
|
HA
|
A:HIS501
|
4.8
|
20.0
|
1.0
|
NE2
|
A:HIS501
|
4.8
|
18.2
|
1.0
|
HB3
|
A:LEU497
|
4.8
|
23.1
|
1.0
|
HG
|
B:LEU497
|
4.8
|
33.1
|
0.6
|
HD23
|
A:LEU497
|
4.9
|
25.6
|
1.0
|
HG23
|
B:ILE487
|
4.9
|
23.2
|
1.0
|
HD21
|
B:LEU497
|
4.9
|
23.7
|
0.4
|
ND1
|
B:HIS501
|
4.9
|
19.6
|
1.0
|
CD2
|
B:LEU497
|
4.9
|
19.8
|
0.4
|
CD1
|
B:ILE487
|
5.0
|
21.0
|
1.0
|
|
Sodium binding site 2 out
of 3 in 7nfb
Go back to
Sodium Binding Sites List in 7nfb
Sodium binding site 2 out
of 3 in the Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na603
b:23.9
occ:1.00
|
HE2
|
A:HIS356
|
2.1
|
21.7
|
1.0
|
O
|
A:HOH829
|
2.8
|
19.7
|
1.0
|
NE2
|
A:HIS356
|
3.0
|
18.1
|
1.0
|
CL
|
A:CL611
|
3.0
|
25.6
|
1.0
|
CD2
|
A:HIS356
|
3.8
|
17.6
|
1.0
|
HD2
|
A:HIS356
|
3.8
|
21.2
|
1.0
|
HD13
|
A:LEU327
|
4.0
|
23.9
|
1.0
|
CE1
|
A:HIS356
|
4.0
|
18.7
|
1.0
|
HD22
|
A:LEU327
|
4.0
|
25.0
|
1.0
|
HB3
|
A:ARG352
|
4.0
|
22.1
|
1.0
|
HD21
|
A:LEU327
|
4.1
|
25.0
|
1.0
|
HE1
|
A:HIS356
|
4.1
|
22.5
|
1.0
|
HD11
|
A:LEU327
|
4.3
|
23.9
|
1.0
|
HD2
|
A:ARG352
|
4.3
|
27.8
|
1.0
|
CD2
|
A:LEU327
|
4.5
|
20.8
|
1.0
|
CD1
|
A:LEU327
|
4.6
|
19.9
|
1.0
|
HG2
|
A:ARG352
|
4.6
|
25.3
|
1.0
|
O
|
A:HOH907
|
4.7
|
25.8
|
1.0
|
O
|
A:HOH917
|
4.7
|
41.0
|
1.0
|
HH11
|
A:ARG352
|
4.8
|
26.5
|
1.0
|
CB
|
A:ARG352
|
4.9
|
18.4
|
1.0
|
O
|
A:ARG352
|
4.9
|
17.5
|
1.0
|
|
Sodium binding site 3 out
of 3 in 7nfb
Go back to
Sodium Binding Sites List in 7nfb
Sodium binding site 3 out
of 3 in the Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Er-Prs*(+) (Y537S) in Complex with Genistein and Src-2 Coactivator Peptide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na602
b:41.8
occ:1.00
|
HA
|
B:SER334
|
2.2
|
48.3
|
1.0
|
HB3
|
B:SER334
|
2.5
|
50.8
|
1.0
|
CA
|
B:SER334
|
2.8
|
40.2
|
1.0
|
CB
|
B:SER334
|
3.0
|
42.3
|
1.0
|
N
|
B:SER334
|
3.1
|
38.7
|
1.0
|
HB2
|
B:SER334
|
3.1
|
50.8
|
1.0
|
HB2
|
B:PRO333
|
3.3
|
43.9
|
1.0
|
H
|
B:SER334
|
3.4
|
46.4
|
1.0
|
C
|
B:PRO333
|
3.5
|
38.0
|
1.0
|
O
|
B:PRO333
|
3.6
|
41.4
|
1.0
|
C
|
B:SER334
|
4.2
|
40.0
|
1.0
|
CB
|
B:PRO333
|
4.2
|
36.6
|
1.0
|
OG
|
B:SER334
|
4.3
|
45.0
|
1.0
|
CA
|
B:PRO333
|
4.4
|
34.9
|
1.0
|
HG
|
B:SER334
|
4.7
|
54.0
|
1.0
|
O
|
B:SER334
|
4.7
|
40.9
|
1.0
|
HB3
|
B:PRO333
|
4.8
|
43.9
|
1.0
|
OD1
|
B:ASP332
|
4.9
|
32.9
|
1.0
|
HD2
|
B:PRO333
|
4.9
|
38.8
|
1.0
|
|
Reference:
M.Kriegel,
H.J.Wiederanders,
S.Alkhashrom,
J.Eichler,
Y.A.Muller.
A Pross-Designed Extensively Mutated Estrogen Receptor Alpha Variant Displays Enhanced Thermal Stability While Retaining Native Allosteric Regulation and Structure. Sci Rep V. 11 10509 2021.
ISSN: ESSN 2045-2322
PubMed: 34006920
DOI: 10.1038/S41598-021-89785-1
Page generated: Tue Oct 8 18:09:42 2024
|